Detalhe da pesquisa
1.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Lancet Oncol
; 23(12): 1571-1582, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36370716
2.
Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study.
Breast Cancer Res Treat
; 191(2): 477-480, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34817748
3.
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1458-1467, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34543613
4.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34875670
5.
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial.
Future Oncol
; 17(26): 3445-3456, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34044585
6.
Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Int J Mol Sci
; 22(8)2021 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33917181
7.
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.
Int J Cancer
; 147(1): 160-169, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31724170
8.
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients.
Future Oncol
; 16(22): 1629-1637, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32501121
9.
PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy.
Int J Mol Sci
; 21(15)2020 Jul 27.
Artigo
Inglês
| MEDLINE | ID: mdl-32727102
10.
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations.
Int J Mol Sci
; 21(22)2020 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33182542
11.
Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.
Int J Mol Sci
; 21(22)2020 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33266496
12.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31029508
13.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29956884
14.
Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
J Neurooncol
; 144(1): 211-216, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31273578
15.
Correction to: Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
J Neurooncol
; 145(1): 189, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31502041
16.
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?
Future Oncol
; 15(15): 1717-1727, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30977687
17.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29482983
18.
Nivolumab in previously untreated melanoma without BRAF mutation.
N Engl J Med
; 372(4): 320-30, 2015 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-25399552
19.
Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
Oncology
; 94 Suppl 1: 29-33, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30041177
20.
Role of mTOR Signaling in Tumor Microenvironment: An Overview.
Int J Mol Sci
; 19(8)2018 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-30126252